Literature DB >> 8848353

Decreased expression of placental growth hormone in intrauterine growth retardation.

J A Chowen1, D Evain-Brion, J Pozo, E Alsat, L M García-Segura, J Argente.   

Abstract

During normal pregnancy, the levels of placental GH in the maternal circulation increase significantly until 35 wk of gestation. We have previously shown that these levels are significantly reduced in cases of intrauterine growth retardation (IUGR). To better understand the basis of this observation, we have studied the expression of placental GH in placentas from normal births (n = 6) and births with IUGR (n = 5). In situ hybridization histochemistry was used to determine the mean number of cells per area expressing this message, as well as the mean level of specific mRNA per cell. We have found that the mean mRNA signal level per cell of placental GH did not differ between normal or IUGR placentas. However, the mean number of cells/ area expressing this mRNA was significantly greater in normal placentas compared with IUGR placentas (normal 12.8 +/- 0.9 cells/unit area, IUGR 4.9 +/- 2.4 cells/unit area, analysis of variance: p < 0.004). These data suggest that the decreased levels of placental GH in the maternal circulation in IUGR are not due only to the reduced size of the placenta, but also to changes in the placental tissue which result in a reduced number of cells per area that are capable of producing this peptide.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8848353     DOI: 10.1203/00006450-199604000-00028

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

Review 1.  Growth hormone. A paracrine growth factor?

Authors:  S Harvey; K L Hull
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

2.  Differential expression profile of growth hormone/chorionic somatomammotropin genes in placenta of small- and large-for-gestational-age newborns.

Authors:  Jaana Männik; Pille Vaas; Kristiina Rull; Pille Teesalu; Tiina Rebane; Maris Laan
Journal:  J Clin Endocrinol Metab       Date:  2010-03-16       Impact factor: 5.958

Review 3.  Placental growth hormones.

Authors:  Marie-Christine Lacroix; Jean Guibourdenche; Jean-Louis Frendo; Guillaume Pidoux; Danièle Evain-Brion
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

4.  The growth hormone receptor gene deleted for exon three (GHRd3) polymorphism is associated with birth and placental weight.

Authors:  Raja Padidela; Sinead M Bryan; Sayeda Abu-Amero; Rebecca E Hudson-Davies; John C Achermann; Gudrun E Moore; Peter C Hindmarsh
Journal:  Clin Endocrinol (Oxf)       Date:  2012-02       Impact factor: 3.478

5.  Placental dysfunction is associated with altered microRNA expression in pregnant women with low folate status.

Authors:  Bernadette C Baker; Fiona L Mackie; Samantha C Lean; Susan L Greenwood; Alexander E P Heazell; Karen Forbes; Rebecca L Jones
Journal:  Mol Nutr Food Res       Date:  2017-03-21       Impact factor: 5.914

6.  Insulin-like growth factor axis in pregnancies affected by fetal growth disorders.

Authors:  Aamod R Nawathe; Mark Christian; Sung Hye Kim; Mark Johnson; Makrina D Savvidou; Vasso Terzidou
Journal:  Clin Epigenetics       Date:  2016-01-27       Impact factor: 6.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.